Soligenix

$1.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-5.76%) Today
+$0.01 (+0.76%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Soligenix and other stocks, options, and ETFs commission-free!

About SNGX

Soligenix, Inc. Common Stock, also called Soligenix, is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare disease.

CEO
Christopher J. Schaber
Employees
18
Headquarters
Princeton, New Jersey
Founded
1987
Market Cap
54.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
772.03K
High Today
$1.38
Low Today
$1.29
Open Price
$1.38
Volume
923.08K
52 Week High
$2.99
52 Week Low
$1.21

SNGX Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 14, Pre-Market

You May Also Like

NYMX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure